This HTML5 document contains 196 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.3324/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36366626
rdf:type
wikibase:Item
schema:description
২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012년 논문 vědecký článek vedecký článok სამეცნიერო სტატია наукова стаття, опублікована в червні 2012 wissenschaftlicher Artikel научная статья 2012年學術文章 مقالهٔ علمی 2012年学术文章 article científic artigo científico (publicado na 2012) vetenskaplig artikel artikull shkencor tieteellinen artikkeli 2012年學術文章 artículo científico publicado en 2012 article scientifique (publié 2012) επιστημονικό άρθρο bilimsel makale vitskapeleg artikkel научни чланак artículu científicu espublizáu en 2012 2012年学术文章 мақолаи илмӣ 2012年學術文章 articol științific teaduslik artikkel سائنسی مضمون artigo científico мақолаи илмӣ научна статия 2012年學術文章 articolo scientifico wetenschappelijk artikel 2012 nî lūn-bûn научни чланак գիտական հոդված artykuł naukowy vitenskapelig artikkel scienca artikolo 2012年学术文章 artigo científico (publicado na 2012) tudományos cikk article scientific บทความทางวิทยาศาสตร์ 2012年學術文章 artikulong pang-agham 2012年の論文 מאמר מדעי naučni članak مقالة علمية نشرت بتاريخ 11-6-2012 2012年學術文章 2012年学术文章 scientific article bài báo khoa học 2012年学术文章 videnskabelig artikel (udgivet 2012) mokslinis straipsnis
p:P577
wds:Q36366626-994BE14B-2EDA-41A5-A10E-E7F9F54C7AC6
wdt:P577
2012-06-11T00:00:00Z
p:P2860
wds:Q36366626-58A078DD-8676-4319-A016-1FFC8208A993 wds:Q36366626-59DDBF79-C37E-4BFE-BA9D-4A449A4AFDE7 wds:Q36366626-645A1877-8CC5-42CD-845E-C0E3576ED1D4 wds:Q36366626-67578AEA-BBDF-4943-8600-8E77E1A4B585 wds:Q36366626-67E6BAF9-33FB-4B90-833A-4FB966BCAFB0 wds:Q36366626-6D04ED8A-A682-4639-A8B2-6808C56585CE wds:Q36366626-70028ACC-0315-4B52-BAE4-39651C3C10E7 wds:Q36366626-76C6C9A3-AF19-41BC-9BD7-DDF537700470 wds:Q36366626-7862E251-76A6-41E0-A8F3-769E45C31F79 wds:Q36366626-7F3AA772-1A98-40E3-8520-982F4D0FA644 wds:Q36366626-89CB2617-0534-4726-8A8C-A9123EB74114 wds:Q36366626-B0ABCF0D-73A8-412E-8D57-B62213E3EE1D wds:Q36366626-2FE94F28-E045-4875-88A1-41133BA9CB18 wds:Q36366626-3E76AE52-FF07-4BD1-A869-43A1F7FFD545 wds:Q36366626-4718350D-1091-4C12-A884-2438DA547D0C wds:Q36366626-4F11A77B-A705-4BC7-A907-0F4086937ADF wds:Q36366626-510040DB-BE2A-4F7B-B308-A72DCB423724 wds:Q36366626-5157E475-333E-43AE-BAFB-A476ED3EBEEB wds:Q36366626-539BB73A-2810-4327-9745-24BD6B921B79 wds:Q36366626-56B464F4-336F-4100-AC7B-390AB18E327B wds:Q36366626-5746443E-1DB0-40B2-98C9-2427DF93248C wds:Q36366626-FF126E69-2E3F-4622-BA90-2980D9F699B3 wds:Q36366626-C612CFA5-7F32-423B-A928-1CEE62155004 wds:Q36366626-C8B0A138-BB29-446F-8FD8-F526888459E1 wds:Q36366626-D0951BE6-C687-4784-943E-962E96CA65BD wds:Q36366626-DABD342A-3048-4F80-A374-744CBDF3340E wds:Q36366626-E3C7BA93-32CA-4C4C-AAC0-2F01492D1A5F wds:Q36366626-E997F1C9-A6B0-4305-8A0C-28CEEA43230A wds:Q36366626-EE635E44-43F9-4218-BBAA-DC5DAABBB74A wds:Q36366626-FB1B1F5C-4D14-45B2-A2C1-917762280E0F wds:Q36366626-0ACC2C6B-DA45-4971-953E-0728FF4FE174 wds:Q36366626-0F593F08-AB34-4C56-9BC8-59A4625FA0CA wds:Q36366626-17162FC4-E538-478E-81CF-F0CFFDBA1DE4 wds:Q36366626-1ADEE710-1838-432F-849C-FE9F3C481D11 wds:Q36366626-1CEA6B58-D890-43C1-BD47-F1442B794020 wds:Q36366626-1E1AC148-B465-4D89-BA15-402BF46B865D wds:Q36366626-1E652F11-E6DF-4E80-BDCC-1ABF8F55097E wds:Q36366626-202E223B-8DDC-443D-88AE-893EA229C95B wds:Q36366626-273F2C2D-E47F-4935-AB43-5E2028C77997 wds:Q36366626-27992761-12DE-4FF8-A634-9A48877B3238
wdt:P2860
wd:Q27860558 wd:Q28268694 wd:Q27851423 wd:Q34706808 wd:Q24597817 wd:Q27851723 wd:Q34104350 wd:Q37239907 wd:Q38870039 wd:Q46630294 wd:Q57376122 wd:Q36807146 wd:Q33997232 wd:Q39654335 wd:Q36057887 wd:Q34139321 wd:Q35083630 wd:Q53218722 wd:Q35808597 wd:Q45977906 wd:Q24533270 wd:Q35804449 wd:Q29547463 wd:Q62017172 wd:Q35848425 wd:Q47915859 wd:Q34441541 wd:Q41299772 wd:Q37460343 wd:Q40182316 wd:Q37879077 wd:Q36251939 wd:Q42485394 wd:Q28242368 wd:Q34127380 wd:Q39611503 wd:Q40132729 wd:Q37460333 wd:Q34451540 wd:Q54531407
p:P2093
wds:Q36366626-DAF6D835-4A1B-46FE-AE21-12D1223F3AF3 wds:Q36366626-AE0B85DE-286B-48EC-8CA5-86EDC43C0646
wdt:P2093
Francesco Lanza Manuele Ongari
rdfs:label
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status
skos:prefLabel
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status
schema:name
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status
p:P50
wds:Q36366626-1BE57816-4678-4228-8CF8-7E07A1689E56 wds:Q36366626-1E5373FC-DDA5-466C-A1F8-3A8D91242FB2 wds:Q36366626-39CA5E47-02B0-495A-B34F-F78C515618CD wds:Q36366626-3BA9B8F7-7013-47A8-A7F1-E4C148200302 wds:Q36366626-342071F6-079C-4EF5-A2A4-0BA10A4FFD5A wds:Q36366626-F49943A0-717B-4857-9E83-279FF6E972DE wds:Q36366626-BEABA809-2277-4A6D-83E6-748936581A5A
wdt:P50
wd:Q114717333 wd:Q114717345 wd:Q39063030 wd:Q114717346 wd:Q39507349 wd:Q39507392 wd:Q114717334
p:P1476
wds:Q36366626-281C66D3-B87D-4E19-A0CF-7C99FD0EF8D1
wdt:P1476
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status
p:P304
wds:Q36366626-AE37CD78-9DD2-40FA-84CA-3D14B97F8664
wdt:P304
1722-1730
p:P31
wds:Q36366626-B1FE26BE-97FD-4555-A66A-5D5E55DAE649
wdt:P31
wd:Q13442814
p:P921
wds:Q36366626-EE894B0B-0889-46FC-A957-0CFDE519F863 wds:Q36366626-11397EAF-7F9A-46D3-BB91-CE2E443AC0AA
wdt:P921
wd:Q29496 wd:Q246181
p:P698
wds:Q36366626-4FB5F1F7-0C70-4FED-B383-6341B3E5AC9C
wdtn:P698
n10:22689683
wdt:P698
22689683
p:P1433
wds:Q36366626-CB6DEBB5-F82C-439C-9EA9-3E912C61C6E1
wdt:P1433
wd:Q5638209
p:P433
wds:Q36366626-F505E726-B82F-4767-8304-443CB76F08D3
p:P478
wds:Q36366626-F8A4ADFC-246F-43D3-AFA4-F37DF945FA4A
wdt:P433
11
wdt:P478
97
p:P356
wds:Q36366626-AF910257-48D6-4FEC-B085-D7DD5BBF4907
wdtn:P356
n12:HAEMATOL.2012.062083
wdt:P356
10.3324/HAEMATOL.2012.062083
p:P5875
wds:Q36366626-54CAA4BC-7B00-4144-B197-27915E2E3E22
wdt:P5875
225293491
p:P932
wds:Q36366626-30F13C34-5058-4C38-AF86-EE0371ADC975
wdt:P932
3487447